of these nine cases with T-PLL is discussed.
Mononuclear cells were isolated by Lymphoprep density gradient centrifugation (Nyegaard, Oslo, Norway) and washed Introduction three times in Hank's balanced salt solution (Gibco, Grand Island, NY, USA). Sezary syndrome (SS) is a well-recognised disorder of mature Transmission electronmicroscopy studies were carried out (post-thymic) T lymphocytes characterised by skin and blood on blood cells fixed in 3% glutaraldehyde (TAAB, Reading, involvement. Skin infiltration typically presents with an UK) in 0.1 M phosphate buffer saline, pH 7.4. Osmication, intensely pruritic erythroderma associated with a variable dehydration and embedding were performed following standegree of lymphadenopathy and, less commonly, hepatodard techniques. and/or splenomegaly. The clinical course is generally chronic, Membrane markers were assessed by indirect immunofluophototherapy or radiotherapy controlling the skin infiltration rescence using a panel of monoclonal antibodies (McAb) and for years until increasing peripheral blood or visceral involvea fluorescein-conjugated antimouse immunoglobulin (Ig) Fab2 ment necessitate systemic chemotherapy. Circulating abnorfragment as the second layer (Cappel, West Chester, UK). Two mal lymphocytes designated Sezary cells are characterised by percent pooled human AB serum was used throughout to a high nucleo-cytoplasmic ratio and highly convoluted or avoid non-specific binding to Fc receptors. The monoclonal 'cerebriform' nuclei which appear hyperchromatic on light antibodies used were: CD2 (RFT11), CD3 (UCHT1), CD4 (Leu microscopy. Large (15-20 m) and small cell (8 m) variants 3a), CD5 (UCHT2), CD7 (3A1), CD8 (Leu 2a), anti-TCR ␣/␤ of Sezary cells have been described. 1 The neoplastic cells (WT1), CD25 (IL-2R), anti-HLA-DR (GRB1). Reactivity was have a mature (TdT − ) T cell phenotype and are usually CD4 + , estimated on a FACScan flow cytometer gating in the lymph-CD8 − with half of cases being CD7 negative. T cell clonality oid population. Control populations included substitution of has been established by T cell receptor (TCR) gene rearrangethe McAb by a non-specific mouse Ig of the same isotype. A ment studies. 2 result was considered positive when over 30% of neoplastic The differential diagnosis of SS includes the whole spectrum cells were positive with the McAb. of post-thymic T cell malignancies, in particular T prolymphoCytogenetics were carried out after 3-5 days culture at 37°C cytic leukaemia (T-PLL) and adult T cell leukaemia/lymphoma with 5% CO 2 . Cells were resuspended in RPMI-1640 medium (ATLL), in which the neoplastic cells are also CD4 + CD8 − and (Gibco) with 20% fetal calf serum with or without addition of display an irregular nucleus. Around 30% of cases of T-PLL phytohemagglutinin, TPA and interleukin-2. Harvesting, fixation and Giemsa trypsin banding were performed according to standard methods. 
Patients
The clinical characteristics of the nine patients are summarised in Table 1 . There were five females and four males with a median age of 52 years (range 33-75). The patients had lymphocytosis ranging from 12.7 to 133 × 10 9 /l (median 20.8 × 10 9 /l), splenomegaly (five cases), lymphadenopathy (three cases) and hepatomegaly (two cases). Thrombocytopenia (platelets Ͻ100 × 10 12 /l) was seen in half of the cases but anaemia (Hb Ͻ10 g/dl) in only two. Bone marrow (BM) infiltration was seen in all cases tested. Lymphocytes ranged from 20-90% of nucleated cells in the BM aspirate and trephine biopsies usually showed an interstitial pattern of infiltration. Skin infiltration was not present at diagnosis in any cases but developed as a terminal event in two of them (cases 5 and 7). This manifested as skin thickening in case 5 and a
Figure 1
Peripheral blood from case 1 showing small cells with maculopapular rash in case 7 but both progressed to frank highly convoluted nuclei and scanty cytoplasm.
erythroderma. Post-mortem skin histology in case 5 showed a lymphoid infiltrate in the dermis in contrast to the epidermotropism characteristic of SS, which was seen in case 7. Two patients had central nervous system (CNS) involvement, case 3 presenting with a hemiparesis and case 7 relapsing with headaches and Horner's syndrome 14 months after diagnosis.
Abnormal lymphocytes identical to those in the peripheral blood were detected in cerebrospinal fluid (CSF) in both cases (100 and 420 cells/mm 3 , respectively) and a CT scan in case 7 showed cerebral edema and meningeal enhancement with a meningeal mass related to the posterior falx.
Light microscopy examination showed in six cases a predominant population of small lymphocytes with scanty, agranular cytoplasm, hyperchromatic nuclei, deep nuclear indentations and no visible nucleoli (Figures 1 and 2 ). In case 8, the cells were larger, and in cases 7 and 9, were of intermediate size, but all had nuclear characteristics similar to the former cases. Electronmicroscopy revealed that lymphocytes in all cases had serpentine nuclei with several deep indentations (length of indentation/maximal nuclear diameter Ͼ0.66) resembling Sezary cells ( Figures 3 and 4 ). Heterochromatin
Figure 2
Peripheral blood from case 4 showing one large cell and many small cells with highly convoluted nuclei.
was marginated in the periphery. Nucleoli were prominent in 50% of cells in case 9 but were not prominent in the other cases. 
15 was expressed in six patients. Only case 4 was negative for all T cell markers but T cell receptor (TCR) gene rearrangement was detected by the polymerase chain reaction (PCR) and the cells were positive with the McAb TIA-1 against the TCR-and TIA-2 against cytotoxic T lymphocytes. 7 The activation antigens CD25 and HLA-DR were negative in all cases tested.
In case 6, serological assays were positive for HTLV-I whereas all other cases were seronegative and five cases tested by PCR revealed no LTR, gag, env, pol or tax sequences of HTLV-I. 6 Cytogenetic analysis in three patients revealed complex chromosomal abnormalities. In two cases (cases 1 and 7) both isochromosome 8q and inversion 14(q11;q32) were present ( Figure 5 ) and in case 2, t(X;14)(q28;q11) was detected.
The patients were treated with a wide range of chemo- due to abdominal distension but had no effect on the systemic disease. Spleen histology showed predominant involvement of the red pulp with heavy diffuse lymphocytic infiltration.
Responses to steroids and alkylating agents were minimal. Patient 4 went into complete remission (CR) with CHOP and this response was maintained for 26 months. Five patients received deoxycoformycin (DCF) resulting in two partial remissions but no response in other patients. The longest survivor (case 1) had a partial response to DCF then attained CR with the humanised monoclonal antibody CAMPATH-1H which lasted for 21 months. A subsequent relapse was treated with further CAMPATH-1H and this resulted in a second CR lasting 6 months. Patient 6 also went into CR with CAMPATH-1H and cutaneous lesions in case 7 regressed with this therapy. Both patients attaining CR after treatment with CAM-PATH-1H (cases 1 and 6) underwent bone marrow harvesting. Patient 1 underwent additional peripheral blood stem cell (PBSC) collection and both this and his BM harvest were free Neoplastic lymphocytes in the nine unusual cases of T cell PCR+, positive result in polymerase chain reaction.
leukaemia described resembled Sezary cells morphologically, a Cells were positive with TIA-1 (anti-TCR-) and TIA-2 monoclonal antibodies.
with cerebriform or serpentine nuclei showing peripheral con-
Figure 5
Karyotype of a metaphase from patient 7 with Sezary cell leukemia: 44,XY, der(6)t(6;11)(q12;q11), i(8)(q10),−11,add12(p13),−13,der(14)t(14;?)(p12;?)inv(14)(q11;q32),mar1. densation of heterochromatin. However, clinical and labora-T cell lymphomas evolving into leukaemia 8 but is unusual in other mature T cell leukaemias apart from T-PLL in which it tory features were different from those seen in SS.
The most striking clinical difference of our nine cases from occurs in 20% of cases, 13 in common with 33% of the patients with Sezary cell leukaemia reported here. Skin involvement SS was that none of the patients presented with skin lesions. Two cases developed skin infiltration at a pre-terminal stage:
occurs in T-PLL in approximately one quarter of cases but, in contrast to SS, erythroderma is unusual and lymphoid infilcase 5 lacked histological features characteristic of SS while case 7 showed epidermotropism. The patients were younger tration is preferentially dermal without epidermotropism (as seen in case 5). 14 Sezary cell leukaemia, like T-PLL, is rapidly (median age 52 years vs 73 years in SS) and predominantly female whereas SS is more common in elderly males. 8 CNS progressive and resistant to alkylating agents with a median survival of 7.5 months. 13 However, remarkable responses to involvement was seen in 2/9 patients but is very rare in SS. 9 The clinical course was aggressive with poor response to the humanised monoclonal CDw52 antibody, CAMPATH-1H, have recently been observed in T-PLL. 15 The longest survivor chemotherapy and a median survival of 13 months. By contrast, classical SS generally runs a more chronic course and in the current series of Sezary cell leukaemia (case 1) attained a durable CR with CAMPATH-1H with no evidence of miniphototherapy or radiotherapy may control skin infiltration for years until florid peripheral blood involvement and/or organmal residual disease as assessed by molecular techniques and his disease remained sensitive to this therapy even after omegaly necessitate systemic chemotherapy. Median survival in SS varies from 10 years (in patients with no adverse progrelapse, a second CR being attained. Another important similarity between Sezary cell leukaemia and T-PLL is the presnostic features) to 18 months (in those with two or more adverse characteristics such as age Ͼ65 years, erythroderma, ence in one-third of the cases of chromosomal abnormalities considered characteristic of T-PLL, namely inversion 14, visceral and PB involvement). 10 Laboratory features of our cases were also different from t(X;14)(q28;q11) and isochromosome 8q (iso 8q). Inversion 14 (q11;q32), present in two cases of Sezary cell leukaemia, is those of SS. Neoplastic lymphocytes in SS usually display a CD4 + CD8 − phenotype (82% of cases) 8 and this was seen in seen in 42-72% of cases of T-PLL 13, 16 and is thought to result in the juxtaposition of the TCR alpha or delta chain genes only one of the nine cases studied. The latter was HTLV-I seropositive but had no known risk factors for HTLV-I infection, (14q11) with a candidate oncogene, TCL-1 (14q32). 17 Similarly, the translocation t(X;14)(q28;q11), seen in one case of being Caucasian and originating from a non-endemic area (Greece). Although the majority of lymphocytes in this case Sezary cell leukaemia, results in juxtaposition of the TCR genes with another proto-oncogene, MTCP1, which is thought were identical to small Sezary cells, some polylobated cells were seen. Sezary-like cells can be identified in up to oneto be analogous with TCL1. 18 Inversion 14 (q11;q32) is not specific to T-PLL but trisomy 8, including iso8q which occurs third of ATLL cases but constitute a minority (Ͻ10%) of the whole population in contrast to their predominance in this in 48-53% of cases of T-PLL, 13, 15 is only rarely seen in other chronic lymphoproliferative disorders 15 and was seen in two patient. 5 HTLV-I-type retroviral particles and sequences have been reported in cases of mycosis fungoides and SS but of our Sezary cell leukaemia cases. None of these three chromosomal abnormalities appear to be primary events in Tmainly in seronegative individuals and the significance of such findings remains controversial.
11, 12 Although clonality of PLL or are sufficient for leukaemogenesis, additional genetic changes being required. HTLV-I proviral integration was not investigated in this patient it is likely that the more precise diagnosis in this HTLV-I-posi-
The clinical, immunophenotypic and cytogenetic data presented here suggest a great similarity between Sezary cell tive case was ATLL rather than Sezary cell leukaemia.
In contrast to the above differences from SS, the similarities leukaemia and T-PLL. This, plus the remarkable sensitivity to CAMPATH-1H seen in two patients allowing harvesting of BM between Sezary cell leukaemia and T-PLL are striking. Coexpression of CD4/CD8 occurs in around 10% of peripheral and PB stem cells free of minimal residual disease in one,
